Clinical Trial Update: Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to Ocrelizumab

View source ↗

Summary

Clinical trial evaluating the safety and efficacy of switching relapsing-remitting multiple sclerosis patients from natalizumab to ocrelizumab, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Natalizumab (natalizumab)
• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Providence Health & Services | Conditions: Relapsing Remitting Multiple Sclerosis | Status: COMPLETED | Results posted: 2024-09-19